PACS Group (NYSE:PACS) CEO Jason Hulse Murray Sells 31,358 Shares of Stock

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 31,358 shares of the firm’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $46.02, for a total transaction of $1,443,095.16. Following the sale, the chief executive officer owned 54,148,039 shares of the company’s stock, valued at $2,491,892,754.78. The trade was a 0.06% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Wednesday, November 4th, Jason Murray sold 167,434 shares of PACS Group stock. The shares were sold at an average price of $50.24, for a total value of $8,411,884.16.
• On Tuesday, November 3rd, Jason Murray sold 26,504 shares of PACS Group stock. The shares were sold at an average price of $46.50, for a total value of $1,232,436.00.
• On Thursday, October 29th, Jason Murray sold 1,904 shares of PACS Group stock. The shares were sold at an average price of $50.05, for a total value of $95,295.20.
• On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The stock was sold at an average price of $50.10, for a total value of $345,639.90.
• On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The stock was sold at an average price of $48.60, for a total value of $3,349,366.20.
• On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The stock was sold at an average price of $47.55, for a total value of $651,244.80.
• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total value of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total value of $1,785,779.05.
• On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The shares were sold at an average price of $47.57, for a total value of $77,063.40.
• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total value of $402,875.82.

PACS Group Trading Up 8.5%

NYSE:PACS opened at $50.63 on Thursday. The stock has a fifty day simple moving average of $44.42 and a 200 day simple moving average of $39.91. The firm has a market capitalization of $8.01 billion, a price-to-earnings ratio of 21.32, a price-to-earnings-growth ratio of 1.46 and a beta of -0.14. PACS Group, Inc. has a 1-year low of $10.31 and a 1-year high of $51.68. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21.

PACS Group (NYSE:PACS) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.05. PACS Group had a return on equity of 33.39% and a net margin of 4.87%. The firm had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.46 billion. Sell-side analysts forecast that PACS Group, Inc. will post 2.13 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on PACS. Royal Bank Of Canada boosted their price target on shares of PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a report on Thursday, August 6th. Wall Street Zen lowered shares of PACS Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 8th. UBS Group lifted their price objective on shares of PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Oppenheimer boosted their target price on shares of PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Finally, JPMorgan Chase & Co. increased their target price on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a report on Friday, September 4th. Five analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $58.80.

PACS Group News Summary

Here are the key news stories impacting PACS Group this week:

• Positive Sentiment: PACS reported third-quarter 2026 earnings of $0.63 per share, above estimates of $0.56–$0.58 and up from $0.32 a year earlier. Revenue of $1.50 billion also topped forecasts of $1.46 billion, supporting the positive market reaction. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 Earnings and Revenues Beat Estimates
• Negative Sentiment: CEO Jason Murray, director Mark Hancock, and chief accounting officer Michelle Lewis reported share sales. The sales could raise a modest concern about insider sentiment, but they were conducted under Rule 10b5-1 plans; Murray and Hancock continued to hold roughly 54 million shares each. CEO Form 4 filing Director Form 4 filing Chief accounting officer Form 4 filing

Hedge Funds Weigh In On PACS Group

A number of large investors have recently made changes to their positions in the business. Financial Management Professionals Inc. lifted its position in shares of PACS Group by 54.9% in the second quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after purchasing an additional 235 shares in the last quarter. GK Wealth Management LLC acquired a new stake in shares of PACS Group during the third quarter worth approximately $41,000. KBC Group NV purchased a new position in PACS Group during the first quarter valued at approximately $42,000. USA Financial Formulas purchased a new position in PACS Group during the third quarter valued at approximately $46,000. Finally, Western Wealth Management LLC purchased a new position in PACS Group during the first quarter valued at approximately $48,000.

About PACS Group

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.